Evaluating the efficacy of ivermectin as an ovicidal against aedes aegypti and aedes albopictus. Combivent without prescripton was administered orally once a day for 4 weeks to 30 children (mean age 9.2 years) with hyperkinetic movement disorder and to 30 age- and sex-matched controls. Two hundred sixty-two dogs (185 cats) were evaluated; these included dogs in a boarding kennel and the dogs that stayed during 1 year at the animal clinic.